Filtered By:
Condition: Bleeding
This page shows you your search results in order of relevance. This is page number 4.
Order by Relevance | Date
Total 57721 results found since Jan 2013.
Unprovoked Venous Thromboembolism: The Search for the Cause
Med Clin North Am. 2023 Sep;107(5):861-882. doi: 10.1016/j.mcna.2023.05.006. Epub 2023 Jun 26.ABSTRACTVenous thromboembolism (VTE) is a common vascular disorder encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE). There is no data on global estimates of VTE prevalence and incidence. Most patients with unprovoked VTE require secondary thromboprophylaxis upon the completion of the primary treatment phase if they have no high bleeding risk. Risk prediction models can help identify patients at low VTE recurrence risk who may discontinue anticoagulation upon the completion of the primary treatment phase.PMID:375...
Source: The Medical Clinics of North America - August 4, 2023 Category: General Medicine Authors: Hunter Mwansa Mohamed Zghouzi Geoffrey D Barnes Source Type: research
Understanding partial protection and HIV risk and behavior following voluntary medical male circumcision rollout in Kenya
In the midst of scaling up voluntary medical male circumcision (VMMC) in Kenya, there is concern that men do not adequately understand that circumcision provides only partial protection against HIV. The study goal was to determine men’s understanding of partial protection, perceptions of HIV risk before and after VMMC and use of protective measures following VMMC. In-depth interviews with 44 men aged 18–39 years recently circumcised or planning to undergo VMMC were conducted in two urban and rural districts in Nyanza Province, Kenya. Participants described partial protection as the need to continue using other ...
Source: Health Education Research - January 17, 2014 Category: Research Authors: L'Engle, K., Lanham, M., Loolpapit, M., Oguma, I. Tags: ORIGINAL ARTICLES Source Type: research
Venous thromboembolism: reducing the risk in a Role 3 setting
Conclusions
Inclusion of pre-printed LMWH/GECS prescriptions and risk assessment stickers in the mediction chart significantly improved rates of VTE risk assessment and prophylaxis. These easily reproducible and low-cost interventions could improve patient safety on deployment.
Source: Journal of the Royal Army Medical Corps - November 17, 2014 Category: Journals (General) Authors: Craig, D. G., Adam, M. G., Proffitt, A., Parsons, I., Tai, N. R., d'Arcy, J. L. Tags: Patients, Epidemiologic studies, Drugs: cardiovascular system, Venous thromboembolism, Medical error/ patient safety, Quality improvement Original article Source Type: research
The Impact of an Evidence-Based Education on Complementary and Alternative Medicine Usage in People with Cancer: Pilot Study
This study aimed to determine whether the implementation of a CAM education influenced decision-making with regard to CAM usage amongst cancer patients. Twe nty people with cancer were recruited for participation in this study. The aims of this study were achieved by surveying patients via questionnaire, both prior to and following receiving an evidence-based CAM education, in either or both written or audiovisual format. This exploratory study found, c onsistent with the literature, that the majority of participants were obtaining their CAM use information from non-evidenced-based sources. Additionally, it found that the ...
Source: Journal of Cancer Education - March 12, 2020 Category: Cancer & Oncology Source Type: research
Injectable Foam Blocks Internal Bleeding on the Battlefield
Despite their best efforts to stabilize abdominal wounds sustained on the battlefield, military first-responders have few options when it comes to stanching internal bleeding caused by, for example, gunshots or explosive fragments. The Defense Advanced Research Projects Agency (DARPA) says it is studying a new type of injectable foam that molds to organs and slows hemorrhaging. This could provide field medics with a way to buy more time for soldiers en route to medical treatment facilities. [More]
Source: Scientific American - Official RSS Feed - February 4, 2013 Category: Science Tags: Technology,Chemistry,Health,Physics,Medical Technology,More Science,Biotechnology,Biotechnology,Biology Source Type: research
Medical 'superglue' shows promise for heart surgery
Conclusion
This innovative glue has shown promise during animal experiments involving rats and pigs. The consistency and technique of "fixing" the glue appears to show some advantages for new surgical techniques, but there are some limitations that need to be addressed before it can be tested in humans.
The researchers mention that the "rapid curing" (the light treatment process) helped avoid exposure to high temperatures, but it is not clear what effect the UV light may have on surrounding tissues. The animals were also only followed up for a short period of time after the surgery. It would be importa...
Source: NHS News Feed - January 9, 2014 Category: Consumer Health News Tags: Heart/lungs Medical practice Source Type: news
SAM Medical Launches New Bleeding Control Kits for Novice and Experienced Users
News Higlights:
- SAM Medical brings the most essential supplies together to empower everyone to become first responders
- New SAM Medical Bleeding Control Kits feature the award-winning SAM XT Extremity Tourniquet, an easy-to-use “click, twist and secure” tourniquet anyone can use
- The SAM XT Extremity Tourniquet is an approved emergency medical device through the Department of Defense’s Stop the Bleed licensing program
- SAM Medical opens new e-commerce site, making its entire product line available to the public for the first time ever
WILSONVILLE, Ore. -- SAM Medical, an industry leader in the pre-hospital, trau...
Source: JEMS Patient Care - February 28, 2019 Category: Emergency Medicine Authors: SAM Medical (press release) Tags: Trauma Press Releases Source Type: news
Halt Medical wins reimbursement for Acessa fibroid treatment
Halt Medical said yesterday that its Acessa treatment for symptomatic firbroids is now covered by Blue Cross Blue Shield of Michigan.
Acessa uses radiofrequency ablation guided by ultrasound to remove fibroids, which are benign, non-cancerous tumors that occur in women’s uteri, often during childbearing years, Halt Medical said.
“Millions of women suffer from heavy bleeding, pain and bloating due to fibroids, but prefer to avoid the risks and long recovery of a hysterectomy, so they just endure these debilitating symptoms. Now there is Acessa, a less invasive option that significantly reduces or eliminates the...
Source: Mass Device - July 9, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Ultrasound Women's Health Blue Cross Blue Shield Halt Medical Source Type: news
IT-CARES: an interactive tool for case-crossover analyses of electronic medical records for patient safety
Discussion IT-CARES may enhance patient safety by facilitating clinical epidemiological studies of adverse events following medical procedures. The tool’s usability must be evaluated and improved in further research.
Source: Journal of the American Medical Informatics Association - September 26, 2016 Category: Information Technology Authors: Caron, A., Chazard, E., Muller, J., Perichon, R., Ferret, L., Koutkias, V., Beuscart, R., Beuscart, J.-B., Ficheur, G. Tags: Research and Applications Source Type: research
St. Vincent ’s Medical Center Takes Emergency Preparedness to a Higher Level
BRIDGEPORT, Connecticut – For St. Vincent’s Medical Center, safety and emergency preparedness are critical to its role in serving the Bridgeport community. St. Vincent’s continually evaluates and assesses the needs of the community at its sites of care to ensure they have the proper safety-related resources and protocols in place. This month, St. Vincent’s further strengthened its relationship with the Bridgeport Police Department, while improving its own resources to enhance emergency preparedness.
Protecting Bridgeport’s Finest
Earlier this week, St. Vincent’s Medical Center Foundation presented the Bri...
Source: JEMS Patient Care - August 16, 2017 Category: Emergency Medicine Authors: St. Vincent's Medical Center Tags: Patient Care Industry News Source Type: news
H & H Medical Announces Product Mobile App for IOS and Android
WILLIAMSBURG, VIRGINIA - H&H Medical Corporation, a leading manufacturer and supplier of emergency first aid products, announced today the availability of a mobile application for users to learn about H&H Medical products, how they treat severe injuries and medical emergencies, and step-by-step instructions on how to use them.
The app was designed to help users quickly identify the products they might need to treat a particular medical emergency. While not designed as a training tool, the app does provide information about products for treating severe bleeding, sealing chest wounds, addressing a tension pneumothora...
Source: JEMS Operations - August 30, 2017 Category: Emergency Medicine Authors: H & H Medical Tags: Operations Industry News Source Type: news
Inari Medical touts FlowTriever pulmonary embolism study data
Inari Medical today presented results from a study of its FlowTriever retrieval and aspiration system designed to treat pulmonary embolism, touting the safety and efficacy of the system.
Results were presented by Dr. Thomas Tu of Louisville, Ky.’s Baptist Health at the Scientific Sessions of the Society for Cardiovascular Angiography and Interventions in San Diego, Irvine, Calif.-based Inari Medical said.
“The significant improvement in right heart function shown with the FlowTriever system compares very favorably with outcomes of other techniques used to treat PE. At the same time, the impressive safety profil...
Source: Mass Device - April 30, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Vascular Inari Medical Source Type: news
Cook Medical wins FDA de novo nod for Hemospray
Cook Medical said yesterday it won FDA de novo clearance for its Hemospray endoscopic hemostat designed for treating bleeding in the gastrointestinal tract.
The Hemospray product won indications from the FDA for treating non-variceal GI bleeds, the Bloomington, Ind.-based company said. Hemospray is a single-use device designed to deliver an aerosolized spray of a mineral blend to a bleeding site during endoscopic procedures, and can cover large areas including ulcers and tumors, according to an FDA release.
“We are extremely pleased to receive this approval to market from FDA. We have worked diligently to bring a di...
Source: Mass Device - May 8, 2018 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Cook Medical Source Type: news
